Guru Ownership Trend
Guru Analysis for UroGen Pharma Ltd. (URGN)
UroGen Pharma Ltd. (URGN), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $102.54 M.
Top institutional holders include Jefferies Group and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $6 M net outflow during the quarter.
On the selling side, Cliff Asness reduced exposure by 6.1%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for UroGen Pharma Ltd. (URGN)
Major holders include Jefferies Group ($39.55 M), Cliff Asness ($2.59 M), Catherine Wood ($2.08 M). According to the latest reported data, 3 tracked investment managers collectively hold approximately 2.46 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $6 M, with 0 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited URGN. The total reported sell value was $6 M.
No tracked managers opened new positions or increased their holdings in URGN during the most recent reporting period.